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Abstract
Background: In epilepsy, seizures are generated by abnormal synchronous activity in neurons. In the rat
hippocampus (HIP), epileptiform activity has been found to be associated with gap junctions (GJs). GJs are formed
by the combination of two hemichannels, each composed of six connexins. At low doses, the convulsive drug
4-aminopyridine (4-AP) produces epileptiform activity without affecting glutamate levels; therefore, GJs could
participate in its effect. Based on this argument, in this study, the expression of Cx 32, Cx 36 and Cx 43 protein and
mRNA in the HIP of rats treated with 4-AP was evaluated. The evaluation of connexins was carried out by
chemifluorescent immunoassay, semiquantitative RT-PCR and immunofluorescence to detect the amount and
distribution of connexins and of cellular markers in the HIP and dentate gyrus (DG) of animals treated with NaCl
and 4-AP in the right entorhinal cortex. In these animals, convulsive behavior and EEG signals were analyzed.
Results: The animals treated with 4-AP showed convulsive behavior and epileptiform activity 60 min after the
administration. A significant increase in the protein expression of Cx 32, Cx 36 and Cx 43 was found in the HIP
contralateral and ipsilateral to the site of 4-AP administration. A trend toward an increase in the mRNA of Cx 32 and
Cx 43 was also found. An increase in the cellular density of Cx 32 and Cx 43 was found in the right HIP and DG,
and an increase in the cellular density of oligodendrocytes in the DG and a decrease in the number of cells marked
with NeuN were observed in the left HIP.
Conclusions: Cx 32 and Cx 43 associated with oligodendrocytes and astrocytes had an important role in the first
stages of seizures induced by 4-AP, whereas Cx36 localized to neurons could be associated with later stages.
Additionally, these results contribute to our understanding of the role of connexins in acute seizures and allow us
to direct our efforts to other new anticonvulsant strategies for seizure treatment.
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Background
Epilepsy is a neurological disease that affects 2-5 % of
the population worldwide; 67 million people have epi-
lepsy [1]. In epilepsy, recurrent seizures are generated by
abnormal synchronous activity in a group of neurons
[2]. Currently, the cellular mechanisms involved in the
generation of epilepsy are not known in detail. In vitro
studies in the rat hippocampus have found epileptiform
activity in the absence of chemical synapses. This fact
suggests that other mechanisms may be involved in epi-
lepsy, such as electrotonic coupling between cells [3–5].
Electrotonic coupling is produced by gap junctions
(GJs). GJs are intercellular connections formed by the
addition of two hemichannels called connexons. Every
connexon is formed by six structural transmembrane
proteins, called connexins (Cxs). Cxs 26, 30, 32, 36, 43,
and 47 are expressed in the rodent hippocampus [6, 7].
Astrocytes express Cxs 30, 43 and 26, oligodendrocytes
express Cxs 29, 32 and 47, and neurons express Cxs 36
and 45 [8, 9]. The union of two connexons forms a
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channel through which ions and small molecules
(<1000 Da; AMPc and IP3) pass bidirectionally [10, 11].
Several in vitro and in vivo studies have found a relation
between GJs and epileptiform activity [12–14]. In this re-
spect, GJ blockers, such as carbenoxolone, octanol and
quinine, have an antiepileptic effect [15–20], whereas GJ
openers, such as trimethylamine, facilitate epileptiform ac-
tivity [17, 21]. Additionally, some authors have reported
changes in the expression of Cxs 30, 32, 36 and 43 in seiz-
ure and epilepsy models [15–17, 22–27] as well as in pa-
tients with mesial temporal lobe epilepsy [28–31].
Nevertheless, the results of these studies are contradictory.
There is evidence of the importance of Cxs in brain func-
tion. Animals in which different Cxs have been knocked
out exhibit alterations in gamma oscillations [32] and
myelination, neuronal hyperexcitability [33], and a reduc-
tion of calcium waves [28, 34]. Some Cxs knockout lines
even exhibit epileptiform activity and changes in gluta-
matergic transmission in the hippocampus [35, 36]. There
is electrical coupling between hippocampal cells and in
the entorhinal cortex [37–39]. These limbic structures
have a role in the hypersynchronization that underlies epi-
leptiform activity, and these brain regions are important
sites for seizure generation [12, 20, 40].
4-Aminopyridine is a convulsant drug that blocks po-
tassium channels and prolongs the action potentials of
neurons; this effect facilitates the nonspecific release of
neurotransmitters such as glutamate in the hippocampus
and striatum [41, 42]. Low doses of 4-AP have been ob-
served to produce epileptiform activity without affecting
glutamate levels [43, 44], suggesting that other mecha-
nisms could be involved in seizure generation in this
model, such as GJs. For this reason and because there
have not been any studies that have addressed these is-
sues, in the present study we evaluated protein and
mRNA expression of Cxs 32, 36 and 43 in the hippo-
campus and dentate gyrus (DG) of freely moving rats
treated with 4-AP in the right entorhinal cortex (rEC).
Methods
Animal surgery
Twenty-eight adult male Wistar rats (250–300 g in
weight) were used in the present study. All rats were
maintained in individual cages in a temperature-
controlled room with a 12-h light/dark cycle, with ad
libitum access to food and water. All experimental pro-
cedures were designed to minimize animal suffering
and the total number of animals used. This protocol
conformed to the Rules for Research in Health Matters
(Mexican Official Norms NOM-062-ZOO-1999, NOM-
033-ZOO-1995) and was approved by the local Animal
Care Committee.
Rats were first anesthetized with isoflurane in 100 %
O2 and then secured in a Stoelting stereotaxic frame
with the incisor bar positioned at −3.3 mm. A stainless
steel guide cannula (0.5 mm internal diameter) was im-
planted into each rat through a hole drilled in the skull,
and it was positioned in the rEC at the following stereo-
taxic coordinates relative to bregma (rEC: AP, −8 mm; L,
4.6 mm; V, 4 mm). This cannula was used to insert an
injection needle (V, 5 mm) that also served as a record-
ing electrode. The entire surface of the cannula was in-
sulated except for a 1 mm portion of its tip. Three
stainless steel screws were attached to the skull, one
above bregma and two above the cerebellum, which
served as the ground and the reference electrodes, re-
spectively. Three surface electrodes with the same char-
acteristics as the electrodes described above were
implanted into the skull over the right frontal cortex
(rFC), the left frontal cortex (lFC) and the left occipital
cortex (lOC). The guide cannula and surface electrode
wires were attached to a socket connector and fixed to
the skull with acrylic dental cement. This procedure was
completed in animals from both the control and the ex-
perimental group to perform the EEG recordings as well
as for the immunoassay tests. Animals used to evaluate
mRNA and immunohistochemistry by fluorescence were
implanted only with the guide cannula.
Drug administration and EEG recording
After surgery, the animals were allowed to recover for
24–48 h and then divided into experimental groups
and treated as follows: 3 control groups (one group
with n = 4 and two groups with n = 3) received an in-
jection of the vehicle alone (NaCl, 0.9 %), and 60 min
after the injection the animals were sacrificed; and 3
experimental groups of animals (n = 6 per group) were
injected with 10 nmol 4-AP and sacrificed similarly,
60 min after the injection.
4-AP (Sigma, MO, USA) was diluted in the appropri-
ate concentration of NaCl to maintain iso-osmolarity.
Both the vehicle and 4-AP solutions were injected locally
into the rEC at a flow rate of 1.0 μl/min for 1 min (final
volume: 1 μl) using a microsyringe mounted on a micro-
injection pump (WPI SP101, FL, USA).
The rats were placed in a containment unit, and the
electrodes were connected to a cable fixed to a balanced
arm. EEG activity was recorded using a Grass polygraph
model 6 with a low-frequency filter at 1 Hz and a high
frequency filter at 300 Hz and was sampled at 100 Hz/
channel (four channels). Data were stored on a com-
puter hard disk and analyzed with AcqKnowledge soft-
ware from Biopac Systems MP150 (Biopac Systems, Inc.,
CA, USA). After recording basal activity for 30 min, ve-
hicle or 4-AP (10 nmol) was administered. Then, the an-
imals were observed continuously for 60 min, during
which time EEG activity was recorded. The basal elec-
trical activity of each group was analyzed, and the
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amplitude and frequency were averaged over a 5 min re-
cording period. The data from the experimental groups
were analyzed by measuring the amplitude of a single epi-
leptiform discharge over a 3 min period of the recording.
Amplitudes were sampled at different times after the drug
administration. The frequency of the EEG epileptiform ac-
tivity (the number of single epileptiform discharges during
a 1 s seizure period) was averaged manually for 3 min for
each of the different periods of time studied. Propagation
of this epileptiform activity to other areas was also
analyzed.
Behavioral study
Animal behavior was scored by continuous observation
before, during and after vehicle or drug administration,
using a modified version of the Racine scale [19]. Briefly,
behavior was scored as follows: 0, behavioral arrest (mo-
tionless), piloerection, excitement and rapid breathing; 1,
movement of the mouth, lips, tongue and vibrissae as
well as salivation; 2, head and eye clonus; 3, forelimb
clonus, “wet dog shakes”; 4, clonic rearing; 5, clonic rear-
ing with a loss of postural control and uncontrolled
jumping.
Synaptosome and glial membrane extraction
Connexin proteins are localized in nerve terminals (syn-
aptosomes) and glial membranes; therefore, we used the
method of Li and coworkers [45] to extract them. After
60 min of vehicle or 4-AP administration, animals from
the control and experimental groups belonging to the
first set of experiments were decapitated, and the right
and left hippocampus were extracted and weighed. Next,
the tissue was homogenized in cold PBS (pH 7.3;
0.12 M) containing 0.32 M sucrose, 1 mM NaHCO3,
1 M MgCl2 and 0.5 mM CaCl2 by applying 12–24
strokes (800 rpm; 50 % amplitude) with an ultrasonic tis-
sue processor (Cole-Parmer, IL, USA). Then, the homog-
enized solution was centrifuged for 10 min (1400 X g).
The supernatant was collected, and the nuclear precipi-
tate was homogenized and centrifuged for 10 min (1400
X g); this last supernatant was combined with the previ-
ous supernatant, and they were centrifuged for 30 min
(13800 X g). The precipitate obtained contained crude
synaptosomes and mitochondria, and this precipitate
was suspended in cold phosphate-buffered saline (PBS,
0.12 M; pH 7.3) to be used in the immunoassay.
Immunoassay by chemifluorescence
This procedure was performed according to Hendrix and
coworkers [45] with some modifications. Microplates of
96 wells with a solid support were used; the plates con-
tained protein G in order to fix the primary antibody
(Thermo Scientific, IL, USA). In every microplate, a pri-
mary antibody for Cx 32 (anti-mouse polyclonal antibody;
Zymed, CA, USA), Cx 36 (anti-rabbit polyclonal antibody;
Santa Cruz Biotechnology, CA, USA) and Cx 43 (anti-
rabbit polyclonal antibody; Santa Cruz Biotechnology, CA,
USA), diluted 1:500 with PBS (0.12 M, pH 7.3), was incu-
bated overnight at 4 °C. After that, three washes with PBS
were applied, each for 10 min with shaking. The micro-
plates were then incubated with blocking solution (0.12 M
PBS, pH 7.3; 0.01 % NaN3; and 1 % bovine serum albumin
(BSA), pH 7.6) for 1 h at room temperature with shaking.
Then, three 10 min washes with PBS containing Tween
20 (0.02 %) and NaN3 (0.01 %) and shaking were per-
formed, followed by one 10 min wash with PBS and shak-
ing at room temperature. Then, the synaptosome and glial
membrane extracts in the microplates were incubated
with diluted blocking solution for 10 min with shaking at
room temperature. After that, the appropriate secondary
antibody coupled to horseradish peroxidase (IgG anti-
rabbit or IgG anti-mouse; Abcam, CA, USA), diluted
1:500 in blocking solution, was added to every microplate
to incubate for 1 h. After that, three washes of 10 min
each were performed with PBS containing Tween 20
(0.02 %) and NaN3 (0.01 %) and shaking. Subsequently,
one wash of 10 min with only PBS was performed. Finally,
the reaction mixture (Amplex-enhancer solution, 10-
acetyl-3,7-dihydroxyphenoxazine (ADHP) and stable per-
oxidase (QuantaRed Enhanced Chemifluorescent HRP
Substrate Kit; Thermo Scientific, IL, USA) was added to
every microplate and incubated in the dark for 10 min at
room temperature with shaking. The reaction was stopped
with a QuantaRed stop solution (Thermo Scientific, IL,
USA), which was added to every microplate for 15 s while
shaking. Immediately, the chemifluorescence was read in
each well of the microplates with a CCD detector (USB
4000, Ocean Optics) that contained two optic fibers. The
excitation wavelength was 570 nm and the emitted light
was captured at 585 nm.
Semiquantitative RT-PCR of connexins
After 60 min of vehicle or 4-AP administration, animals
from the control and experimental groups belonging to
the second sets of experiments were decapitated, and
the right and left hippocampi were extracted and
weighed. Each hippocampus was preserved at −80 °C in
1 ml of Trizol RNA extraction reagent, as indicated by
the manufacturer (Invitrogen, CA, USA). The defrosted
hippocampus was homogenized, and approximately
50 mg of this material was used for each RNA extrac-
tion. To determine the integrity of the total RNA ex-
tracted, agarose gel electrophoresis was used, whereas
the concentration and purity of the total RNA was
probed using a spectrophotometer (LABOMED, CA,
USA). cDNA was synthesized from 500 ng total RNA
using oligo-dT12–18 and M-MLV reverse transcriptase as
indicated by the manufacturer (Invitrogen, CA, USA).
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The cDNA was amplified with a variation of PCR called
multiplex-PCR, in which two or more primers are used
in the same reaction mixture. cDNA (2 μl) was added to
the reaction mixture (23 μl), which contained: dNTP
Mix, 0.4 mM; PCR buffer, 1X; MgCl2, 4 mM; Taq DNA
Polymerase, 2U final concentration (Invitrogen, CA,
USA) and the different primers (forward and reverse) for
Cx36 and Cx43, 0.4 μM. Another prepared reaction mix-
ture was used for the addition of different primers
(0.4 μM) (forward and reverse) for Cx32 and β-actin
(constitutive gene). The conditions used for the multi-
plex RT-PCR were standardized to amplify both the
Cx36/Cx43 and Cx32/ β-actin mixtures, as follows: ini-
tially 95 °C for 15 min for denaturation; 35 cycles of
95 °C for 50 s; 57 °C for 1 min for hybridization; 72 °C
for 1 min for elongation; and a final incubation at 72 °C
for 7 min. This procedure was carried out with a ther-
mocycler (T100 Bio-Rad, CA, USA). The characteristics
of the primers used (IDT, Inc, CA, USA) are shown in
Table 1. Ten microliters of the PCR products were sep-
arated by electrophoresis. The gel was stained with eth-
idium bromide, and the results were documented using
Kodak I.D. Image analysis software, Version 3.5 (New
Haven CT, USA). The data were normalized to the con-
stitutive gene β-actin. Each sample was tested in tripli-
cate for each connexin and the constitutive gene.
Perfusion and immunofluorescence
After 60 min of vehicle or 4-AP administration, animals
from the control and experimental groups for the third
set of experiments were anaesthetized with Nembutal
(60 mg/kg, i.p.) and transcardially perfused with
phosphate-buffered saline (PBS, 0.1 M, pH 7.4, 37 °C),
followed by 4 % paraformaldehyde (in 0.1 M PBS,
pH 7.4) containing 0.1 % glutaraldehyde. The animal’s
brain was removed and post-fixed for 12 to 16 h at 4 °C.
The brains were then mounted on a vibratome (WPI,
FL, USA) and sliced coronally at a thickness of 30 μm.
These sections were collected consecutively in separate
wells of an incubation chamber containing PBS, and the
immunofluorescence procedure was performed as de-
scribed previously, with some modifications [22].
Antibodies directed against the Cxs were used, as fol-
lows: 32 (mouse monoclonal antiserum, Invitrogen, CA,
USA), 36 (rabbit polyclonal antiserum, Invitrogen, CA,
USA), and 43 (rabbit polyclonal antiserum, Invitrogen,
CA, USA). Antibodies for the identification of neurons
and glial cells were also used, as follows: NeuN (mouse
monoclonal antiserum, Millipore, CA, USA), oligoden-
drocytes (mouse monoclonal antiserum, Millipore, CA,
USA) and GFAP (rabbit polyclonal antiserum, Invitro-
gen, CA, USA).
Tissue sections were washed twice for 15 min in PBS
(pH 7.4, 0.1 M), and then they were incubated for
30 min at room temperature with shaking in a blocking
solution containing 10 % normal goat serum (NGS) and
0.1 % Triton X-100 in PBS. After three 15 min washes,
the sections were incubated for 48 h at 4 °C with the pri-
mary antibodies (anti-Cx32, anti-Cx36 and anti-Cx43:
1:500; and Anti-NeuN, anti-oligodendrocytes and anti-
GFAP: 1:1000), which were diluted in PBS containing
5 % NGS.
The sections were then washed five times with agita-
tion for 15 min each in PBS and incubated with the sec-
ondary antibody with agitation for 2 h in darkness at
room temperature. Cx36 and GFAP were detected using
goat anti-rabbit IgG-Alexa 594 (1:1000, Invitrogen, OR,
USA) in PBS containing 5 % NGS, whereas oligodendro-
cytes were detected using goat anti-mouse IgG-Alexa
594. Cx32 and NeuN were identified using goat anti-
mouse IgG-Alexa 488 (1:1000, Invitrogen, OR, USA). Fi-
nally, Cx 43 was detected using goat anti-rabbit IgG-
FITC (1:1000, Santa Cruz Biotechnology, CA, USA).
Sections were washed four times in PBS (15 min each)
with agitation in darkness before being mounted on
glass slides and coverslipped using Vectashield (Vector
Laboratories, Inc. Burlingame, CA, USA), to preserve
fluorescence. The sections were examined by fluorescence
microscopy (Olympus, U-LH100HG, Japan) and analyzed
using ImageJ 1.48 software (NIH, MD, USA). Control sec-
tions were incubated without primary antibody or with
Table 1 Characteristics of the primers used in the Semiquantitative RT-PCR of connexins
Gene Primer sequence forward and reverse Nucleotide position NCBI data base ref Expect product (bp) Hybridization temperature (°C)
C × 32 5′-CGGCATCTGCATTATCCTCAAC-3′ 643-664 BC078868.1 163 57
5′-CAGCAGCTTGTTGATCTCATTCTG-3′ 782-805
C × 36 5′-GCAGAGAGAACGCCGGTACT-3′ 424-443 Y16898 270 57
5′-CTTGGACCTTGCTGCTGTGC-3′ 660-679
C × 43 5′-GATGAGGAAGGAAGAGAAG-3′ 493-511 AY324140 620 57
5′-CGCTAGCTTGCTTGTTGTAA-3′ 1096-1105
β-actin 5′-GCAAGAGAGGTATCCTGACC-3′ 260-279 BC063166.1 318 57
5′-CCCTCGTAGATGGGCACAGT-3′ 565-584
[26, 59]
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the primary antibody replaced with NGS, and no fluores-
cence signal was observed in any of the control sections
(data not shown).
Cell counting and cellular density
The somas of neurons and astrocytes, marked with
NeuN and GFAP, respectively, were counted in the CA1
and CA3 regions of the right and left hippocampus as
well as in the DG region, using four slices per animal.
With the 40x objective, three images per region were ob-
tained and analyzed from each slice. The image had an
area of 0.075 mm2; in this area, somas were counted
until three areas per region were analyzed in each rat
[46]. To measure cellular density in the slices stained for
Cxs and oligodendrocytes, pixel intensity was measured
in three fields; each field had an area of 0.075 mm2 and
was obtained with the 40x objective. The analysis was
performed in three fields from each studied region (CA1
and CA3 from the right and left hippocampus and the
DG) obtained from each rat [46].
Histological evaluation
To verify the location of the guide cannula in each ex-
periment, some coronal brain sections (50 μm thick)
were taken from rats previously perfused for immuno-
fluorescence and that belonged to different experimental
and control groups. These sections were stained with
cresyl violet, and if the cannula was implanted incor-
rectly, the animals were excluded from the study.
Data analysis
The EEG results and the immunoassay and immuno-
fluorescence data are shown as the mean (± SEM), while
the RT-PCR data are shown as the percentage change
from the control group (mean ± SEM). Comparisons be-
tween the control and the experimental groups were
performed by applying a Student’s t-test using the
GraphPad Prism 6 statistical software package. Statistical
significance was defined at p < 0.05.
Results
EEG activity in the control and experimental groups
The basal EEG activity of the control animals that re-
ceived NaCl and 4-AP was characterized by physio-
logical slow waves of low amplitude and frequency
(Figs. 1a, b and 2). The group of rats that received an
injection of 4-AP into the rEC developed epileptiform
activity that was initially characterized by hypersyn-
chronous activity, followed by trains of poly-spikes that
increased in amplitude and frequency during the ex-
periment. The trains almost immediately propagated to
all of the regions studied (latency to the first epilepti-
form discharge: rEC, 109 ± 49 s; rFC, 129 ± 42 s; lFC,
262 ± 109 s; and lOC, 132 ± 41 s; Fig. 1). At the end of
Fig. 1 Representative EEG recordings from control (a) and experimental (b) rats in which NaCl (0.9 %) and 4-aminopyridine (4-AP, 10 nmol), respectively,
were injected into the right entorhinal cortex (rEC). These recordings show the basal activity during and at different times after drug administration. No
changes in EEG activity were observed in any of the regions studied (right and left frontal cortex, rFC and lFC, respectively; as well as in the left occipital
cortex, lOC) after NaCl injection (a). The recordings show epileptiform activity of high amplitude and frequency after 4-AP injection (10 nmol) in all of the
studied regions throughout the entire experiment (60 min)
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the experiment (60 min), a slight decrease in the ampli-
tude and frequency of the epileptiform activity was ob-
served (Fig. 2).
Behavior of the control and experimental groups
The saline-treated rats presented normal behavior that
was characterized by periods of sleep, sniffing and
grooming, whereas the 4-AP-treated rats received scores
of 0, 1, 2 and 3 on the modified Racine scale in the first
30 min after 4-AP injection, and one rat received a score
of 5 (Table 2); 60 min after 4-AP injection, only one rat
received a rating of 1 according to the scale; the rest of
the animals continued to be rated as 3 based on the
scale. One 4-AP-treated rat did not necessarily follow
the progression of the Racine Scale and exhibited behav-
ior that was rated as 3 on the scale without having re-
ceived a scale rating of 2 (Table 2).
Immunoassay and RT-PCR of connexins in the control and
experimental groups
Compared with the saline control group, the 4-AP-
treated rats showed a significant increase in the protein
Fig. 2 The graphs represent the mean (±SEM) of the different EEG amplitude and frequency parameters in the right entorhinal cortex (rEC), right and
left frontal cortex (rFC and lFC, respectively) and left occipital cortex (lOC) of the control (NaCl, 0.9 %) and experimental (4-aminopyridine, 4-AP, 10 nmol)
groups during basal activity and at different times after drug administration. Symbols represent: *p< 0.05 vs. control group
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levels of Cxs 32, 36 and 43 in the hippocampus (Fig. 3a).
This increase was higher in the right hippocampus,
which was ipsilateral to the administration of 4-AP into
the rEC.
Analysis of the expression of the mRNA of the differ-
ent Cxs showed a tendency toward increased Cx 32 and
Cx 43 mRNA levels in the right hippocampus in animals
treated with 4-AP compared with the control group
(23 % and 10 %, respectively), but the increase was not
significant. The rest of the Cxs were unchanged in both
the right and left hippocampus (Fig. 3b, c).
Connexin immunofluorescence in the control and
experimental groups
The 4-AP-treated animals showed an increase in the cel-
lular density of Cx 32 and Cx 43 in CA1, CA3 and the
DG of the right hippocampus compared with the control
group (Fig. 4). In the LH, Cx 43 increased in all regions,
whereas Cx 32 was increased only in CA3 with respect
to the control group. Cx 36 did not change in any region
analyzed in both the right and left hippocampus. When
these data were compared with the corresponding cellu-
lar markers (Cx 32 with oligodendrocytes, Cx 36 with
NeuN and Cx 43 with GFAP), only an increase in the
cellular density of oligodendrocytes was found in the
DG of the right hippocampus was found as well as a de-
crease in the number of cells marked with NeuN in the
CA3 region of the left hippocsmpus (Fig. 5). The rest of
the cellular markers remained unchanged in both the
right and left hippocampus.
Discussion
In the present study, local administration of 4-AP (10
nmols) into the rEC produced epileptiform activity,
which was characterized by hypersynchronous activity,
followed by trains of poly-spikes that propagated to all
of the studied regions. This finding is consistent with
previous studies in our laboratory [19, 20]. This epilepti-
form activity coincided with the convulsive behavior that
was associated with a score of 3 on the modified Racine
Scale [19].
An increase in the amount of Cx 32 protein and a ten-
dency toward an increase in the amount of its mRNA
were observed in the right hippocampus of animals
treated with 4-AP (10 nmols, rEC; 60 min after its ad-
ministration). These data suggest a possible relation be-
tween the synthesis of Cx 32 mRNA and protein during
the convulsive event produced by 4-AP. The present
Table 2 Seizure behavior of rats injected with 4-AP (10 nmol,
n = 6) at different times after 4-AP administration
Convulsive behavior after 4-AP injection
RAT Minutes
15 30 45 60
1 0/1 0/1/2/3 0/1/2/3 0/1/2/3
2 0/1/2/3 0/1/2/3 0/1/2 0/1
3 0/1/2 0/1/2/3 0/1/2/3 0/1/2/3
4 0/1/2 0/1/2/3 0/1/2/3 0/1/2/3
5 0/1 0/1/3 0/1/3 0/1/3
6 0/1/2/3 0/1/2/3/4/5 0/1/2/3/4/5 0/1/2/3
The values represent seizure behavior according to the modified Racine Scale
[19]:0, behavioral arrest (motionless), piloerection, excitement and rapid
breathing; 1, movement of the mouth, lips, tongue and vibrissae as well as
salivation; 2, head and eye clonus; 3, forelimb clonus, “wet dog shakes”; 4,
clonic rearing; 5, clonic rearing with a loss of postural control and
uncontrolled jumping
Fig. 3 Panel a shows the mean (±SEM) amount of protein (ng/μg
tissue) found in the right and left hippocampus (RH and LH, respectively)
of connexins 32, 36 and 46 from control (NaCl, 0.9 %) and experimental
rats (4-aminopyridine, 4-AP, 10 nmol). Panel b shows the percentage
change with respect to the control group in the expression of the mRNA
of different connexins in the RH and the LH. c representative images
obtained from control (NaCl)- and experimental (4-AP)-treated rats, in
which the expression of mRNA of different connexins (32, 36 and 43)
was observed
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results are consistent with previous studies in which an
increase in Cx 32 (mRNA and protein) was observed in
neocortex treated with 4-AP [15, 17] as well as in vitro
preparations of the hippocampus treated with bicucul-
line [16]. However, during epileptogenesis, the connec-
tion between Cx 32 mRNA and protein could be found
in specific regions associated with spontaneous seizure
generation because an increase in Cx 32 mRNA has
been observed in the neocortex and hippocampus in pa-
tients with Temporal Lobe Epilepsy [28, 31]. The present
and previous results regarding Cx 32 expression demon-
strate the important role of Cx 32 as a compensatory
mechanism that blocks the convulsive process and epi-
leptogenesis. Accordingly, some experimental evidence
has suggested that Cx 32 expressed in oligodendrocytes
could contribute to the buffering of K+, which is released
during neuronal activity [47, 48], by enabling the se-
quential movement of these ions into the periaxonal
cytoplasm from the soma of the oligodendrocyte
through reflexive junctions. This phenomenon is ex-
tended to a network formed by oligodendrocyte-
astrocyte junctions; in addition, Cx 32/Cx 43 double-
knockout mice show clonic-tonic seizures and early
mortality [49]. Although we found an increase in the
cellular density of Cx 32 in the cells of the right hippo-
campus and DG that correspond to the ipsilateral region
of 4-AP administration (rEC), this increase is also par-
tially consistent with the increase in the cellular density
of labeled oligodendrocytes in the rDG, considering that
Cx 32 is mainly expressed in this type of glial cells.
These results are consistent with previous studies [16,
23] in which an increase of Cx 32 was found in hippo-
campal slices treated with bicuculline (an antagonist of
GABAA receptors).
Additionally, we found a significant increase in Cx 43
protein and a trend toward up-regulation of its mRNA only
in the right hippocampus, ipsilateral to the 4-AP adminis-
tration. These results agree with previous studies in which
an increase in Cx 43 protein was observed in hippocampal
slices treated with pilocarpine and bicuculline [16, 50] as
well with in vivo and in vitro preparations of the neocortex
after 4-AP [15, 17] and bicuculline administration [16]. In
addition, an increase in the mRNA of Cx 43 has been ob-
served in the hippocampus of patients with TLE [29].
Therefore, the present data suggest that Cx 43 protein is
synthesized and distributed in astrocytes under conditions
of constant hyperexcitability for at least 60 min. At this re-
spect, 4-AP increases glutamate levels at synaptic sites
Fig. 4 Representative images obtained with immunofluorescence to Cx 32, Cx 36 and Cx 43 in CA1 and CA3 of the right and left hippocampus
(RH and LH, respectively) as well as in the dentate gyrus (DG) in the control (NaCl, 0.9 %) and experimental groups (4-AP, 10 nmol). Calibration
bar, 50 μm. The right graphs represent the mean ± SEM of the cellular density for Cx 32-, Cx 36-, Cx 43-labelled cells in the three analyzed regions:
CA1 and CA3 of the RH and LH, and the DG. Significant differences between the control and experimental groups were assessed with a
Student’s t-test
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[42, 44] probably activating N-methyl-D-aspartate re-
ceptors (NMDA-R) which increase the intracellular
Ca2+ and produce Ca2+/calmodulin dependent protein
kinase II (CaM-KII) activation, this last protein phos-
phorylates Cx 43 and this effect facilitating coupling
between astrocytes [51, 52] as well as it has been re-
ported a potentiation of the gap junction dependent
on postsynaptic NMDA-R [53, 54] and phosphoryl-
ation of Cx 43 occur following in vitro Co2+−induced
seizures [55]; besides that 4-AP generates hyperexcit-
ability also produces oxidative stress in cells [56] that
could facilitates that more connexins reach the mem-
brane due to a decrease in the endoplasmic reticulum
associated degradation of connexins [57, 58]. Add-
itionally, the increase in Cx 43 in astrocytes could fa-
cilitate and sustain the epileptiform activity in the
hippocampus, as has been demonstrated indirectly in
a model in which carbenoxolone administration
blocked epileptiform activity 60 min after 4-AP ad-
ministration [19]. In addition, the hemi-channels
formed by Cx 43 can be opened after voltage changes
that depolarize the membrane during epileptiform ac-
tivity [59]. ATP and glutamate are also released from
astrocytes through these hemi-channels, producing
neuronal death, as has been observed in epileptic tis-
sue [60]. Additionally, an increase in the cellular dens-
ity of Cx 43 protein was observed in cells of the
hippocampus and DG from the right and left hemi-
spheres in this model of 4-AP; however, we did not
find any significant changes in the number of astro-
cytes in these same regions. This could be due to the
process of glial scar formation over time because it
usually takes several days to see active astrocytes after
seizures [61]. In the present study, the experimental
animals were sacrificed one hour after 4-AP adminis-
tration, when an epileptiform pattern was observed.
We also did not find changes in Cx 36 in neurons
from the hippocampus and DG. In addition, the number
of neurons labeled with NeuN did not differ significantly
between the experimental and the control animals in all
of the studied regions except CA3. These data contrast
with the increase in Cx 36 protein observed in the
hippocampus of the experimental animals of this study.
However, we did not find any changes in Cx 36 mRNA,
which in consistent with previous studies in which no
changes in Cx 36 mRNA were observed in hippocampal
slices exposed to bicuculline [16] or in pilocarpine
model during the acute phase when epileptiform activity
Fig. 5 Representative images obtained with immunofluorescence to oligodendrocytes, NeuN and GFAP in CA3 and the dentate gyrus (DG) of the
right and left hemisphere (RH and LH, respectively) in the control (NaCl, 0.9 %) and experimental groups (4-AP, 10 nmol). Calibration bar, 50 μm.
The right graphs represent the mean ± SEM of the cellular density or cellular counting per area for oligodendrocytes, NeuN- and GFAP-labelled
cells in the three analyzed regions: CA1 and CA3 of the RH and LH, and the DG. Significant differences between the control and experimental
groups were assessed with a Student’s t-test
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was observed [62]; however, another study showed an
increase in Cx 36 mRNA 60 min after the first seizure
[17]. Finally, a third study reported a significant decrease
in Cx 36 mRNA and protein in the hippocampus of rats
treated with kainic acid and kindling [22]. This discrep-
ancy in results could be due to differences in the animals
(ages, strains), the model of seizure induction, the time
of treatment, the duration of seizures before the animals
were sacrificed and the regions analyzed in each study.
However, our results showed an increase in Cx 36 pro-
tein only, that could be explained by a compensation of
the degraded pool of Cx 36 affected by seizures effects
(depolarization, increases in intracellular Ca2+ and oxi-
dative stress in cells) considering the rapid half-life of Cx
36, which is on the order of tens of minutes [63], in con-
trast, the average half-lives of Cx 32 and Cx 43 that are
approximately 1–4 h [64, 65].
Also of interest is the influence of the external and in-
ternal factors that regulate the opening and closing of
the gap junctions through interactions with different
Cxs. Regarding this process, some excitatory and inhibi-
tory amino acids regulate the electrical coupling between
neurons and astrocytes through second messenger sig-
naling systems and kinase proteins [66]. In the present
study, 4-AP slowed membrane repolarization and facili-
tated the release of neurotransmitters, especially glutam-
ate; this neurotransmitter has been shown to influence
the conductance of GJs in the hippocampus and to gen-
erate seizures [42]. Other regulating factors include pH
and the intracellular calcium concentration; increases in
both of these factors decrease the conductance of GJs.
In the present study, the increase of glutamate produced
by 4-AP resulted in the hyperactivation of ionotropic re-
ceptors that also modify the calcium concentration and
pH of postsynaptic neurons, producing hyperexcitability
and modification of the conductance of GJs. In addition,
the alkalization mediated by potassium produced during
the first seizure events increases electrotonic coupling;
later, when it produces acidification at the end of the sei-
zures, this coupling is reduced [67]. Based on these ar-
guments, it is possible to think that the function of GJs
formed by Cxs is altered even if the expression of the
Cxs does not change significantly.
Conclusion
4-AP administration in the rEC produced epileptiform
activity associated with a score of 3 on the modified
Racine Scale. Sixty minutes after the establishment of
this epileptiform pattern, we observed an increase in the
protein expression of Cx 32 and Cx 43, which was
associated with a trend toward an increase in their
mRNA as well as a trend toward an increase in the prin-
cipal marker of oligodendrocytes in the right DG; these
Cxs were also expressed in principal cells of the
hippocampus and DG. Therefore, we suggest that the
Cxs particularly associated with glial cells such as oligo-
dendrocytes and astrocytes have an important role in
the first stages of seizures induced by 4-AP. It is likely
that the participation of Cx 36 in neurons is associated
with the later stages of the acute convulsive process
induced by 4-AP. These results contribute to our under-
standing of the role of Cxs in acute seizures and allow
us to direct our efforts to other new anticonvulsant
strategies for seizure treatment.
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